Published on October 11, 2019
Updated on November 1, 2019
*The “ICYMI” newsletter will change its name to “The Weekly” next month
Researchers Find E-cigarettes Cause Lung Cancer in Mice in First Study Tying Vaping to Cancer
MONDAY, Oct. 7, 2019 (CNBC)—E-cigarette vapor causes lung cancer and potentially bladder cancer in mice, damaging their DNA and leading researchers at New York University to conclude that vaping is likely “very harmful” to humans as well.
“It’s foreseeable that if you smoke e-cigarettes, all kinds of disease comes out” over time, Moon-Shong Tang, the study’s lead researcher, said in an interview. “Long term, some cancer will come out, probably. E-cigarettes are bad news.”
Hawaii To Require Immunizations for Sixth-Grade Students
Oct. 4, Hawaii Public Radio
Scientist Who Discredited Meat Guidelines Didn’t Report Past Food Industry Ties
Oct. 4, New York Times
Broadcasting Video Games is Raising Millions for Charities
Oct. 7, Quartz
Men Who Conceive with Assisted Reproduction at Increased Prostate Cancer Risk
Oct. 10, Reuters
Dr. Andrew C. von Eschenbach honored for leadership in National Lung Screening Trial
THURSDAY, October 10, 2019—The Prevent Cancer Foundation® honored Andrew C. von Eschenbach, M.D. with the James L. Mulshine, M.D. Leadership Award for his work leading the National Lung Screening Trial (NLST), the first large-scale clinical trial for low-dose CT lung cancer screening. The award was presented on October 10, 2019, at the 16th annual Quantitative Imaging Workshop: Lung Cancer, COPD and Cardiovascular Disease.
The award was presented by Jim Mulshine himself, saying, “Andy, you changed the world. 10 years ago, there was profound skepticism around implementing a national lung screening trial and now it’s unbelievable–the world has changed. On behalf of the hundreds of thousands that have been spared the suffering of a lung cancer diagnosis, I thank you for the work you have done.”
More this week…
“Prevention at Every Age” at the 27th Annual Action for Cancer Awareness Awards Luncheon
No Comments